Literature DB >> 5317525

Observations on recent increase in mortality from asthma.

F E Speizer, R Doll, P Heaf.   

Abstract

The mortality attributed to asthma has increased annually in England and Wales from 1960 to 1965. The increase is more pronounced at ages 5 to 34 years than at older ages and is most pronounced at ages 10 to 14 years. In this last age group the mortality increased nearly eight times in seven years, and in 1966 asthma accounted for 7% of all deaths. No comparable increase has been observed in any other country, but smaller increases at ages 10 to 19 years have been observed in Australasia, Japan, western Europe, and the United States. There is no evidence to suggest that there has been any change in diagnostic habits, certification of deaths, or methods of classification which could account for the increase in Great Britain, and it is concluded that the increase is real. General practitioners' records provide no evidence of an increase in prevalence and it seems probable that there has been an increase in case fatality. No environmental hazards are known which could have increased the severity of the disease, and the possibility has to be considered that the increase may be due to new methods of treatment. Corticosteroids have been used increasingly since 1952, and in Great Britain the use of pressurized aerosols containing sympathomimetics has increased rapidly since 1960.

Entities:  

Mesh:

Year:  1968        PMID: 5317525      PMCID: PMC1984843          DOI: 10.1136/bmj.1.5588.335

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  RECENT DEVELOPMENTS IN NEW ORLEANS ASTHMA.

Authors:  H WEILL; M M ZISKIND; V J DERBES; R J HORTON; R O MCCALDIN; R C DICKERSON
Journal:  Arch Environ Health       Date:  1965-02

2.  DEATH FROM ASTHMA IN CHILDREN.

Authors:  W RICHARDS; J R PATRICK
Journal:  Am J Dis Child       Date:  1965-07
  2 in total
  101 in total

1.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

2.  Letter: Amitriptyline and isoproterenol: fatal drug combination.

Authors:  D Kadar
Journal:  Can Med Assoc J       Date:  1975-03-08       Impact factor: 8.262

3.  Trends in hospital admissions for asthma in Lombardy, Italy, 1976-86.

Authors:  M Fasoli; C La Vecchia; M Formigaro; F Repetto
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

4.  A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971.

Authors:  G M Cochrane; J H Clark
Journal:  Thorax       Date:  1975-06       Impact factor: 9.139

5.  Influence of short- and long-term inhalation of salbutamol on lung function and beta 2-adrenoceptors of mononuclear blood cells in asthmatic children.

Authors:  A Schuster; R Kozlik; D Reinhardt
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

6.  The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Authors:  Nicola A Hanania; Supria Singh; Rami El-Wali; Michael Flashner; Amie E Franklin; William J Garner; Burton F Dickey; Sergio Parra; Stephen Ruoss; Felix Shardonofsky; Brian J O'Connor; Clive Page; Richard A Bond
Journal:  Pulm Pharmacol Ther       Date:  2007-07-17       Impact factor: 3.410

7.  Changing digoxin potency and cardiac mortality in England and Wales 1968-76.

Authors:  H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1985-09

8.  Accuracy of death certificates in bronchial asthma. Accuracy of certification procedures during the confidential inquiry by the British Thoracic Association. A subcommittee of the BTA Research Committee.

Authors: 
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

9.  Death from asthma.

Authors:  C Collins-Williams; C Zalesky; K Battu; M T Chambers
Journal:  Can Med Assoc J       Date:  1981-08-15       Impact factor: 8.262

10.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.

Authors:  P Bremner; C Burgess; G Purdie; R Beasley; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.